[HBs-antigenemia and the state of cellular and humoral immunity in children with chronic viral hepatitis B]. 1979

I V Gol'zand, and V O Volkov, and L M Shibova-Borskaia, and L G Nezhentseva, and G S Blagoslovenskiĭ

In chronic virus hepatitis B the causative virus replicates for a long time as manifested by HBsAg persistence. Examinations of 92 sick children revealed changes in cellular and humoral immunity indices. The content of T-lymphocytes (determined according to Bach et al.) was reduced to 31.5 +/- 1.4% in the exacerbation stage (the normal content 50.8 +/- 1.3%), the percentage of O-cells increased, while the number of B-cells according to Mendes et al. did not change significantly. The inhibition of adhesion of A-cells (Halliday et al.--A. F. Blyuger) and "immune" plaque formation (according to A. F. Blyuger) in the presence of HBsAg were also increased maximally in the exacerbation stage. HBs-antigenemia was found to occur most frequently in the exacerbation stage. The content of immunoglobulin G was reduced. An increase in the number of tissue lymphocytes and their blast forms (in the "skin window" sample by Rebuck) was demonstrated. The authors assume that the long-term persistence of HBs-Ag and, consequently, the maintenance of the pathologic process activity are due to a defficiency of cellular immunity factors. The prospects of enhancing cellular immunity in virus hepatitis B in children are discussed.

UI MeSH Term Description Entries
D007104 Immune Adherence Reaction A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell. Adherence Reaction, Immune,Adherence Reactions, Immune,Immune Adherence Reactions,Reaction, Immune Adherence,Reactions, Immune Adherence
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007223 Infant A child between 1 and 23 months of age. Infants
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion

Related Publications

I V Gol'zand, and V O Volkov, and L M Shibova-Borskaia, and L G Nezhentseva, and G S Blagoslovenskiĭ
February 1987, Polski tygodnik lekarski (Warsaw, Poland : 1960),
I V Gol'zand, and V O Volkov, and L M Shibova-Borskaia, and L G Nezhentseva, and G S Blagoslovenskiĭ
May 1976, American journal of clinical pathology,
I V Gol'zand, and V O Volkov, and L M Shibova-Borskaia, and L G Nezhentseva, and G S Blagoslovenskiĭ
June 1981, Polski tygodnik lekarski (Warsaw, Poland : 1960),
I V Gol'zand, and V O Volkov, and L M Shibova-Borskaia, and L G Nezhentseva, and G S Blagoslovenskiĭ
September 1980, Voprosy okhrany materinstva i detstva,
I V Gol'zand, and V O Volkov, and L M Shibova-Borskaia, and L G Nezhentseva, and G S Blagoslovenskiĭ
March 1975, British medical journal,
I V Gol'zand, and V O Volkov, and L M Shibova-Borskaia, and L G Nezhentseva, and G S Blagoslovenskiĭ
December 1983, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
I V Gol'zand, and V O Volkov, and L M Shibova-Borskaia, and L G Nezhentseva, and G S Blagoslovenskiĭ
February 1982, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
I V Gol'zand, and V O Volkov, and L M Shibova-Borskaia, and L G Nezhentseva, and G S Blagoslovenskiĭ
September 1978, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
I V Gol'zand, and V O Volkov, and L M Shibova-Borskaia, and L G Nezhentseva, and G S Blagoslovenskiĭ
September 1983, Clinical nephrology,
I V Gol'zand, and V O Volkov, and L M Shibova-Borskaia, and L G Nezhentseva, and G S Blagoslovenskiĭ
January 1981, Sbornik vedeckych praci Lekarske fakulty Karlovy univerzity v Hradci Kralove. Supplementum,
Copied contents to your clipboard!